The downside of Mounjaro: hair loss and other side effects

In recent years, interest has grown explosively in Weight-loss medications containing a GLP-1 agonist active ingredient interest. Mounjaro (active ingredient: tirzepatide) - like Ozempic - was originally developed to treat type 2 diabetes, but due to its significant weight-loss effect, it is increasingly used for weight loss purposes as well. 

However, alongside the rapid results, more and more users are reporting a side effect that may be off-putting for many: significant hair loss.

Why Can Mounjaro Cause Hair Loss?

It's important to clarify: hair loss is not caused directly by the medication itself. The underlying problem is the extremely rapid weight loss, which puts a serious strain on the body. When the body suddenly sheds a large amount of body weight, it prioritizes vital functions (organ function, metabolism, immunity), and hair growth - as a non-vital process - is pushed into the background, slows down, or may even stop altogether.

This condition is medically known as telogen effluvium, which can be triggered by significant physical or emotional stress (rapid weight loss, childbirth, surgery, a febrile illness). In such cases, large numbers of hairs enter the resting (telogen) phase at once, and then fall out together 2-3 months later. The Mounjaro patient information leaflet also warns that hair loss can be a common side effect.

Can other similar products also cause hair loss?

Mounjaro is not unique in this regard. Other agents in the GLP-1 agonist class, such as Ozempic (semaglutide) or Wegovy, can also be linked to hair loss. With these medications too, hair loss can occur through a similar mechanism, triggered by the stress response to rapid weight loss. It is therefore worth keeping in mind that the appearance of this side effect depends not on the active ingredient, but on the pace of weight loss.

How can hair loss be stopped?

The treatment of hair loss always depends on the type of hair loss involved. Fortunately, telogen effluvium is a reversible condition: if the triggering cause (in this case, rapid weight loss) stops, the hair loss generally resolves on its own within 3–6 months.

However, the available treatment options differ depending on the type and underlying cause of the hair loss we are dealing with

The key to successful treatment is early intervention and precise diagnosis of the type of hair loss.

Women and Men: Not Every Therapy Is Equally Effective

It's an especially important point that not every therapy is effective for both women and men – in fact, some agents can be specifically contraindicated.

• In the case of men, the androgenetic alopecia (hereditary, male-pattern balding) is the most common type, characterized by a progressive decline in hair follicle function. In this case, finasteride can be an effective medical treatment, as it inhibits the production of the hormone (DHT) that causes hair loss.
• In women, hair loss is often caused by hormonal changes (e.g., menopause), when the decrease in estrogen levels disrupts the balance of sex hormones. Finasteride cannot be used in women, as it can cause serious side effects, especially during reproductive age.

In addition, the perception of hair transplants also differs between the two sexes.

The final solution: hair transplant - for whom and when?

A hair transplant (FUE technique), the patient's own hair follicles are transplanted from the donor area at the back of the head to the areas with hair loss. This procedure can be truly effective only if the extent of hair loss is proportionate to the amount of hair available for transplantation.

In men, a hair transplant often brings a visible change after just a few months, and restoring the frontal hairline is the main goal.

For women, however, the situation is different:

For women, achieving the final result can take up to a year. A common problem is that the gap between the possibilities of the donor area and the coverage needed is so large that the surgery may not necessarily result in satisfaction.

In addition, any haircutting that may be needed for the surgery, or any possible hair shedding after the surgery, should be considered separately.

Important: a hair transplant is only worth performing once hair loss has stabilized. If the hair loss is still in an active phase (for example, telogen effluvium), the transplanted hair can also fall out, so the procedure will not produce a result.

The use of Mounjaro and other GLP-1 agonists can result in significant weight loss, but rapid weight loss can lead to hair loss caused by telogen effluvium. The good news is that this condition is reversible: by slowing the pace of weight loss, proper nutrition, and, if necessary, targeted therapies (minoxidil, I-PRF, laser treatment), the hair usually grows back.

At the same time, not every therapy can be used for both sexes - finasteride is specifically designed for men, and its use is prohibited in women. A hair transplant can serve as a final solution, but only in cases of stable, non-progressive hair loss, and it requires more careful judgment in women.

Be sure to consult your treating physician before starting any therapy, and if you experience hair loss while using Mounjaro, be sure to discuss your options with your doctor!